Serotonin2C receptors in the nucleus accumbens are involved in enhanced alcohol-drinking behavior

Eur J Neurosci. 2012 Apr;35(8):1368-80. doi: 10.1111/j.1460-9568.2012.08037.x.

Abstract

Dopamine and serotonin (5-HT) in the nucleus accumbens (ACC) and ventral tegmental area of the mesoaccumbens reward pathways have been implicated in the mechanisms underlying development of alcohol dependence. We used a C57BL/6J mouse model with increased voluntary alcohol-drinking behavior by exposing the mice to alcohol vapor for 20 consecutive days. In the alcohol-exposed mice, the expression of 5-HT(2C) receptor mRNA increased in the ACC, caudate nucleus and putamen, dorsal raphe nucleus (DRN), hippocampus and lateral hypothalamus, while the protein level of 5-HT(2C) receptor significantly increased in the ACC. The expression of 5-HT(7) receptor mRNA increased in the ACC and DRN. Contents of 5-HT decreased in the ACC shell (ACC(S) ) and DRN of the alcohol-exposed mice. The basal extracellular releases of dopamine (DA) and 5-HT in the ACC(S) increased more in the alcohol-exposed mice than in alcohol-naïve mice. The magnitude of the alcohol-induced ACC(S) DA and 5-HT release in the alcohol-exposed mice was increased compared with the control mice. Intraperitoneal (i.p.) administration or local injection into ACC(S) of the 5-HT(2C) receptor antagonist, SB-242084, suppressed voluntary alcohol-drinking behavior in the alcohol-exposed mice. But the i.p. administration of the 5-HT(7) receptor antagonist, SB-258719, did not have significant effects on alcohol-drinking behavior in the alcohol-exposed mice. The effects of the 5-HT(2C) receptor antagonist were not observed in the air-exposed control mice. These results suggest that adaptations of the 5-HT system, especially the upregulation of 5-HT(2C) receptors in the ACC(S) , are involved in the development of enhanced voluntary alcohol-drinking behavior.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Alcohol Drinking / pathology*
  • Alcohol Drinking / physiopathology
  • Aminopyridines / pharmacology
  • Analysis of Variance
  • Animals
  • Biogenic Monoamines / metabolism
  • Central Nervous System Depressants / administration & dosage
  • Central Nervous System Depressants / pharmacology
  • Chromatography, High Pressure Liquid
  • Disease Models, Animal
  • Ethanol / administration & dosage
  • Ethanol / pharmacology
  • Gene Expression Regulation / drug effects
  • Gene Expression Regulation / physiology*
  • Indoles / pharmacology
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Microdialysis
  • Microinjections / methods
  • Nucleus Accumbens / drug effects
  • Nucleus Accumbens / metabolism*
  • Piperidines / pharmacology
  • RNA, Messenger / metabolism
  • Raphe Nuclei / drug effects
  • Raphe Nuclei / metabolism
  • Receptor, Serotonin, 5-HT2C / genetics
  • Receptor, Serotonin, 5-HT2C / metabolism*
  • Receptors, Dopamine / metabolism
  • Serotonin Agents / pharmacology
  • Sulfonamides / pharmacology

Substances

  • 3,N-dimethyl-N-(1-methyl-3-(4-methylpiperidin-1-yl)propyl)benzenesulfonamide
  • 6-chloro-5-methyl-1-((2-(2-methylpyrid-3-yloxy)pyrid-5-yl)carbamoyl)indoline
  • Aminopyridines
  • Biogenic Monoamines
  • Central Nervous System Depressants
  • Indoles
  • Piperidines
  • RNA, Messenger
  • Receptor, Serotonin, 5-HT2C
  • Receptors, Dopamine
  • Serotonin Agents
  • Sulfonamides
  • Ethanol